Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

We’re going Behind the Mystery of two rare diseases: Castleman disease and chondrosarcoma.

There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades. Inhibrx, a clinical-stage biotechnology company, is dedicated to helping people with life-threatening conditions. They are developing a therapeutic option for chondrosarcoma called INBRX-109, which is currently in clinical trials.

Then, meet with physician, scientist, patient, and best-selling author of Chasing My Cure David Fajgenbaum to learn more about Castleman Disease. Plus, one patient’s journey from facing his own mortality to finding hope through advocacy.

Mixing it up in sweet and savory ways: We’re featuring the world-famous, award-winning Angostura® aromatic bitters, orange bitters, and the newly introduced cocoa bitters.

Multiple sclerosis (MS) is an autoimmune condition where the immune system inappropriately attacks the brain and the spinal cord.

What women "auto" know about car insurance, plus living with and managing multiple sclerosis, and mixing it up with Angostura coca bitters.

Comments

comments